Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/17/2023 | Mallinckrodt plc | MNK | Payment of Exercise | Ordinary Shares | 16k | $0.69 | $11.1k | | 08/17/2023 |
06/30/2023 | Mallinckrodt plc | MNK | Disposition | Restricted Stock Units | 168.2k | $0.00 | $0 | | 06/30/2023 |
06/02/2023 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/01/2023 |
06/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 15.8k | $8.70 | $137k | | 06/01/2023 |
06/01/2023 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 4.7k | $0.00 | $0 | | 06/01/2023 |
05/17/2023 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 73.6k | $0.00 | $0 | | 05/17/2023 |
05/17/2023 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 27.2k | $0.74 | $20.1k | | 05/17/2023 |
04/03/2023 | Mallinckrodt plc | MNK | Grant | Restricted Stock Units | 168.2k | $0.00 | $0 | | 04/03/2023 |
12/14/2022 | Mallinckrodt plc | MNK | Grant | | 112.6k | $0.00 | $0 | | 12/14/2022 |
06/16/2022 | Mallinckrodt plc | MNK | Disposition | Ordinary Shares | 11.6k | $0.00 | $0 | | 06/16/2022 |
06/16/2022 | Mallinckrodt plc | MNK | Disposition | Employee Share Options (Right to Buy) | 57.6k | $22.26 | $1.3M | | 06/16/2022 |
06/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 3.4k | $0.00 | $0 | | 06/02/2022 |
06/02/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 15.8k | $14.48 | $228.1k | | 06/02/2022 |
06/02/2022 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/02/2022 |
05/18/2022 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 118.2k | $0.80 | $94.5k | | 05/18/2022 |
05/18/2022 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 87.5k | $0.00 | $0 | | 05/18/2022 |
06/03/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Stock Option (Right to Buy) | 12.2k | $21.90 | $268.3k | | 06/03/2021 |
06/03/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 3.4k | $0.00 | $0 | | 06/03/2021 |
04/20/2021 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 38k | $0.00 | $0 | | 04/20/2021 |
04/20/2021 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 26.9k | $0.00 | $0 | | 04/20/2021 |
04/20/2021 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 38k | $1.71 | $65k | | 04/20/2021 |
12/03/2020 | Mallinckrodt plc | MNK | Sale | Ordinary Shares | 5.4k | $0.17 | $891 | | 12/03/2020 |
06/06/2020 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 7.3k | $0.00 | $0 | | 06/04/2020 |
06/04/2020 | Aclaris Therapeutics, Inc. | ACRS | Grant | Option Grant (right to buy) | 16.5k | $1.41 | $23.3k | | 06/04/2020 |
05/07/2020 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 12.4k | $8.37 | $103.8k | | 05/07/2020 |
05/07/2020 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 8.4k | $0.00 | $0 | | 05/07/2020 |
04/01/2020 | Mallinckrodt plc | MNK | Payment of Exercise | Ordinary Shares | 986 | $1.93 | $1.9k | | 04/01/2020 |
03/02/2020 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 8.9k | $0.00 | $0 | | 03/02/2020 |
03/02/2020 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted stock units | 8.9k | $0.00 | $0 | | 03/02/2020 |
12/05/2019 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 9.2k | $0.00 | $0 | | 12/05/2019 |
06/07/2019 | Mallinckrodt plc | MNK | Purchase | Ordinary Shares | 5.4k | $8.96 | $48.4k | | 06/07/2019 |
06/06/2019 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted Stock Units | 7.3k | $0.00 | $0 | | 06/06/2019 |
05/09/2019 | Societal CDMO, Inc. | REPH | Grant | Common Stock | 8k | $0.00 | $0 | | 05/09/2019 |
05/09/2019 | Societal CDMO, Inc. | REPH | Grant | Stock Option (right to buy) | 10.9k | $8.80 | $95.8k | | 05/09/2019 |
04/01/2019 | Mallinckrodt plc | MNK | Grant | Ordinary Shares | 12.6k | $0.00 | $0 | | 04/01/2019 |
|